The critical question is whether there is an association between the level to which GLP-1 increases and the period of that increment and extent of weight loss post MBS
Additionally, in the trial examining alcohol use disorder, a significant reduction in alcohol consumption was observed only in a specific subgroup of patients with obesity, suggesting that patient characteristics, such as BMI, might influence treatment outcomes
06/06/2024 Calidad biotech, efectiva
It is safe and effective
The evidence base for GLP-1 receptor agonists in post-bariatric weight regain continues to expand, though large randomized controlled trials remain limited compared to primary obesity treatment
Examples include certain migraine medicines, tramadol, lithium, linezolid, methylene blue, St Johns wort, and other antidepressants